During the last session, GlucoTrack Inc (NASDAQ:GCTK)’s traded shares were 0.47 million, with the beta value of the company hitting -0.21. At the end of the trading day, the stock’s price was $0.37, reflecting an intraday gain of 10.15% or $0.03. The 52-week high for the GCTK share is $99.00, that puts it down -26656.76 from that peak though still a striking 16.22% gain since the share price plummeted to a 52-week low of $0.31. The company’s market capitalization is $3.84M, and the average trade volume was 3.78 million shares over the past three months.

GlucoTrack Inc (NASDAQ:GCTK) trade information

GlucoTrack Inc (GCTK) registered a 10.15% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 10.15% in intraday trading to $0.37, hitting a weekly high. The stock’s 5-day price performance is 2.16%, and it has moved by -47.95% in 30 days. Based on these gigs, the overall price performance for the year is -98.79%.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 63.80%.

GCTK Dividends

GlucoTrack Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Also, the Mutual Funds coming in first place with the largest holdings of GlucoTrack Inc (GCTK) shares are Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund . Data provided on Dec 31, 2024 indicates that Fidelity Extended Market Index Fund owns about 1.08 shares. This amounts to just over 0.01 percent of the company’s overall shares, with a $398.0 market value. The same data shows that the other fund manager holds slightly less at 243.0, or about 0.00% of the stock, which is worth about $89.0.